Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Avalon GloboCare

Avalon GloboCare
2014 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
AVCO STOCK SYMBOL
4 INVESTMENTS
$1.53 SHARE PRICE (As of Monday Closing)
Description

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promote and empower high impact, transformative biotechnology, and their clinical applications, and healthcare facility management. It has three reportable segments: real property operating segment which is the key revenue driver; medical-related consulting services segment; and development services and sales of developed products segment. The company focuses on the diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 4400 Route 9 South
  • Suite 3100
  • Freehold, NJ 07728
  • United States

+1 (732) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Avalon GloboCare’s full profile, request a free trial.

Avalon GloboCare Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.40 - $5.63 $116M $1.62 -$0.21 176K 75.8M

Avalon GloboCare Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 138,033 197,289 169,790 147,329
Revenue 1,412 1,562 1,078 616
EBITDA (15,379) (7,219) (3,731) 77
Net Income (15,275) (7,774) (3,464) 56
Total Assets 10,669 13,396 12,669 3,707
Total Debt 590 1,000 1,500 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Avalon GloboCare Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Avalon GloboCare‘s full profile, request access.

Request full access to PitchBook

Avalon GloboCare Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000000 23-Oct-2018 00000 0000000 Drug Discovery 00000 000 00.0
000000 0000000 01-Sep-2018 00000 0000000 Biotechnology 00000 000 00.0
0000000 0000000 (0 25-Oct-2017 000000000000000000 00000 Drug Discovery 00000 000 00.0
Freehold Executive Center 05-May-2017 Corporate Asset Purchase 00.000 Buildings and Property 00000 000 00.0
To view this company’s complete investment and acquisition history, request access »

Avalon GloboCare Executive Team (5)

Name Title Board
Seat
Contact
Info
David Jin Ph.D Chief Executive Officer & Board Member
Luisa Ingargiola Chief Financial Officer
Meng Li Chief Operating Officer & Board Member
Bo Chen Vice President, Mergers & Acquisitions

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

Avalon GloboCare Board Members (4)

Name Representing Role Since Contact
Info
00000 000 00.0 Avalon GloboCare Chief Executive Officer & Board Member 000 0000
0000 00 Avalon GloboCare Chief Operating Officer & Board Member 000 0000
0000000 000000 Avalon GloboCare Board Member 000 0000
0000000 0000000 000 Self Board Member 000 0000